a.kirchner
TL2 · Kristiansand
Contributes reviews on supplier material. Based in Kristiansand.
Joined 11 June 2025 · last posted 2d
80 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #92 · Practice › Interactions · 26 Jul 2026 · 0 likes What I want from this Antibiotics thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
-
What I would want from a home test that does not exist yet Replied, post #48 · Analytics › Home & field testing · 25 Jul 2026 · 26 likes Adding the measurement that post #45 says would settle it. Reconstitution behaviour is a legitimate home observation. A cake that will not dissolve, a solution that…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #103 · Evidence › Journal club · 23 Jul 2026 · 26 likes This settles it for me, at least until somebody posts a reason it should not.
-
Revisiting: Mobile reading experience on long topics Replied, post #15 · Meta › Site feedback · 21 Jul 2026 · 26 likes Post #13 describes the usual case. This is about the unusual one. Agreed, and it matters most on old topics where the person who asked has not been back in two years.…
-
Aggregate verification data across the directory, with caveats Replied, post #56 · Sourcing › Independent verification · 19 Jul 2026 · 23 likes Adding the measurement that post #55 says would settle it. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #63 · Outcomes › Body composition · 18 Jul 2026 · 11 likes Source for the ultrasound and skinfolds figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
-
Here for the analytics and not much else Replied, post #44 · Lounge › Introductions · 16 Jul 2026 · 21 likes No judgment: people come to this community from all backgrounds and with all motivations. Introductions are for getting to know each other, not for evaluation. That is…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #69 · Nutrition & Training › Protein & intake · 16 Jul 2026 · 0 likes Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than trying to hit the whole target at one sitting on suppressed…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #49 · Pharmacology › Pharmacokinetics · 13 Jul 2026 · 13 likes Post #47 and I disagree about the size of the effect, not about the direction. On Peak-to-trough ratio, the part that usually goes wrong is that the question is asked…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #77 · Sourcing › Independent verification · 9 Jul 2026 · 13 likes VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather than vials. Tells you something about a supplier's systems but says nothing…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #17 · Practice › Dosing & titration · 8 Jul 2026 · 12 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #49 · Access › Insurance & coverage · 1 Jul 2026 · 0 likes Post #45 describes the usual case. This is about the unusual one. Keep every document with dates in one place. An appeal months later is assembled from whatever you…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #67 · Outcomes › Progress reports · 29 Jun 2026 · 11 likes A single scale used throughout beats a more accurate scale introduced halfway through. Consistency beats accuracy for a trend. Worth reading the earlier posts in this…
-
Run-in periods and the population they select Replied, post #143 · Evidence › Trials · 25 Jun 2026 · 6 likes Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the simple fact that people who agree to a multi-year…
-
Journal club: what we got wrong in an earlier session Replied, post #20 · Evidence › Journal club · 22 Jun 2026 · 18 likes This follows post #19 rather than contradicting it. The baseline characteristics table is the single most useful page for the questions that get asked here, because it…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #80 · Safety › Contraindications · 20 Jun 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
Transporting a vial for a weekend away — a second dataset Replied, post #84 · Practice › Storage & stability · 16 Jun 2026 · 10 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Not a conclusion.…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #42 · Practice › Administration · 15 Jun 2026 · 22 likes Everything in post #38 holds. The case it does not cover is the one I have. Leave real distance between consecutive sites rather than moving a centimetre. Repeatedly…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #24 · Compounds › Oral incretins · 2 Jun 2026 · 0 likes Post #21 is the version of this I will quote in future. One addition. Anyone comparing published oral and injectable efficacy should check whether the comparison is…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #8 · Practice › Storage & stability · 29 May 2026 · 2 likes Temperature excursions in transit are common and are not all equal. A few hours warm is a different event from three days warm, and neither is visible in the vial on…
-
A site rotation scheme that is easy enough to actually follow Replied, post #55 · Practice › Administration · 4 May 2026 · 1 like Leaving the needle in for a couple of seconds after depressing the plunger reduces leakage at the site. It costs nothing and it is the fix for the "some came back out"…
-
Personal import allowances, compared — a second dataset Replied, post #116 · Access › International · 4 May 2026 · 2 likes Post #115 is right about the mechanism and I think understates the practical bit. Customs and import outcomes: different routes have different seizure rates. Some…
-
Request: show the solution author in the topic list — what changed since Replied, post #61 · Meta › Feature requests · 3 May 2026 · 0 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #59 · Data & Tools › Datasets · 1 May 2026 · 0 likes Good question, well framed, and I would like to see it answered properly.
-
A 10 mg vial reconstituted three different ways, compared Replied, post #17 · Practice › Reconstitution · 30 Apr 2026 · 15 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
The anatomy of a question that gets answered within an hour Replied, post #23 · Start Here › How to Ask · 20 Apr 2026 · 10 likes That reframing is the whole thing. The facts I already had.
-
Type 2 diabetes and the largest part of the evidence base Replied, post #74 · Clinical › Comorbidities · 19 Apr 2026 · 0 likes Post #71 is the version of this I will quote in future. One addition. Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS…
-
Spike-and-recover accuracy for a peptide assay Replied, post #82 · Analytics › Method validation · 9 Apr 2026 · 0 likes Spike-and-recover accuracy looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.
-
Follow-up: State-level differences that actually matter Replied, post #20 · Regional › North America · 4 Apr 2026 · 11 likes Quietly grateful for the plain phrasing. Not every thread gets that.
-
Why the timeline is on the right and not the left — what changed since Replied, post #5 · Meta › Site feedback · 10 Mar 2026 · 1 like Reporting a real defect: on a long topic the jump-to-post link scrolls to the right post but the highlight does not fire on the first load. Second load is fine.…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #12 · Compounds › Semaglutide · 7 Mar 2026 · 17 likes Post #10 and I disagree about the size of the effect, not about the direction. On published dose-response for semaglutide, the part that usually goes wrong is that the…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #57 · Clinical › Bloodwork · 28 Feb 2026 · 1 like Picking up post #56: that is the part I would want checked first. Reference intervals is well covered in the tag pages, and the older discussions are better than the…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #32 · Clinical › Special populations · 22 Jan 2026 · 5 likes Body weight at the extremes of the studied range affects exposure and the trials rarely reported enough to say by how much. That is the shape of it. The detail is where…
-
Substitution between formats during a shortage Replied, post #123 · Access › Shortages · 25 Dec 2025 · 14 likes I read post #121 twice before replying, because I had assumed the opposite. Nothing here is medical advice, and decisions about what to do during a supply interruption…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 22 Dec 2025 · 0 likes I had written a reply contradicting post #12 and deleted it. Here is what survived. Magnesium supplementation is widely recommended in this space with very little…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #39 · Compounds › Semaglutide · 29 Nov 2025 · 5 likes Injection site does not appear to matter much for semaglutide exposure. The published comparisons of abdomen, thigh and upper arm found differences small enough to be…
-
Documentation that materially improves an appeal's chances Replied, post #81 · Access › Insurance & coverage · 28 Nov 2025 · 11 likes Templates in the documentation set are deliberately dull because dullness is what works in this context. That is my reading. Someone else read the same page differently…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Replied, post #19 · Analytics › Method validation · 25 Nov 2025 · 0 likes Narrowing post #16, because the general version has more than one answer. Transfer between laboratories: a method can be transferred from one lab to another, but the…
-
Availability by country, dated, with primary sources — one year on Started this topic · Access › International · 18 Nov 2025 · 0 likes Availability by country, dated, with primary sources — one year on — setting out what I have, and where I think it stops being reliable. Documenting an access outcome,…
-
Cross-border purchase rules within the EU Replied, post #39 · Regional › European Union · 15 Nov 2025 · 0 likes Answering the question post #37 raises rather than the one it answers. Members outside the union should note that essentially none of this transfers, including the…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #56 · Compounds › Tirzepatide · 13 Nov 2025 · 22 likes Second this, and I would have said it less carefully.
-
Publishing an inconvenient result: a case study — the long version Replied, post #30 · Sourcing › Independent verification · 7 Nov 2025 · 8 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #56 · Safety › Adverse events · 25 Oct 2025 · 0 likes Where a symptom began after an escalation and settled after a reduction, that sequence is the strongest observation an individual can contribute. The disagreement above…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #49 · Compounds › Tirzepatide · 19 Oct 2025 · 32 likes Adding the measurement that post #46 says would settle it. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #5 · Pharmacology › Pharmacokinetics · 17 Oct 2025 · 3 likes Genuine question rather than a rhetorical one: has anyone here actually observed Half-life, as opposed to read about it? The thread is long and I cannot tell.
-
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #63 · Practice › Dosing & titration · 14 Oct 2025 · 3 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
Cost per delivered dose, which is the number that matters Replied, post #7 · Access › Pricing · 11 Sep 2025 · 31 likes A cheaper option that arrives slowly has a cost in the form of running out, and people rarely price that.
-
Revisiting: German, French and Dutch differences, compared Replied, post #68 · Regional › European Union · 5 Sep 2025 · 2 likes Pharmacy practice: pharmacies in different EU countries differ in conservatism about irregular prescriptions. Some will decline a prescription they consider irregular;…
-
High-resolution MS on aggregates and what it can see Replied, post #58 · Analytics › Mass spectrometry · 2 Sep 2025 · 21 likes Post #57 answers the question as asked. The question underneath it is different. Resolution: "high resolution" commonly means
-
Counter-ion content and its effect on measured mass Replied, post #109 · Analytics › Mass spectrometry · 1 Aug 2025 · 2 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Canadian access and provincial variation — one year on Replied, post #40 · Regional › North America · 28 Jul 2025 · 0 likes Worth separating two things that post #38 runs together. Canada: Health Canada licenses compounds. Prescribing is provincial. Compounds are prescription-only. Coverage…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #25 · Analytics › COA interpretation · 22 Jul 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #158 · Practice › Reconstitution · 8 Jul 2025 · 8 likes Everything in post #156 holds. The case it does not cover is the one I have. Worked example, since the arithmetic is the whole question. Five milligrams into one…
-
Insulin combinations and hypoglycaemia risk Replied, post #23 · Practice › Interactions · 27 Jun 2025 · 0 likes Confirming post #20 from a second method, which matters more than confirming it from a second person. Adding the boring version of insulin combinations and…
-
Reading a supplier's product description as a marketing document Replied, post #37 · Compounds › Other compounds · 25 Jun 2025 · 0 likes Coming back to post #33, because the follow-up matters more than the original answer. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #56 · Outcomes › Progress reports · 24 May 2025 · 0 likes Building on post #53 rather than restating it. 18-month record was covered in the wiki last year and the page has a review date on it, which is a better starting point…
-
Telehealth prescribing models in the US Replied, post #99 · Regional › North America · 15 May 2025 · 1 like Small methodological point on telehealth prescribing models: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #20 · Evidence › Trials · 2 May 2025 · 20 likes The practical version of Sample size calculations is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions…
-
Reading a trial's population section before its results — does this still hold? Replied, post #45 · Evidence › Trials · 27 Apr 2025 · 5 likes Helpful, and short, which on this subject is harder than long.
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #105 · Compounds › Cagrilintide & amylin analogues · 27 Apr 2025 · 0 likes Post #102 is the version of this I will quote in future. One addition. Having read the whole amylin analogue mechanism thread before replying: the question in the first…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #43 · Practice › Reconstitution · 26 Apr 2025 · 0 likes For anyone finding this later: the short answer on 10 mg vial reconstituted three is that it depends on one thing, and the rest of the thread is people identifying…
-
Asking about a compound your prescriber has not heard of Replied, post #15 · Clinical › Prescriber conversations · 12 Apr 2025 · 22 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations. The…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #3 · Evidence › Trials · 28 Mar 2025 · 2 likes Worth stating the null on Comparators chosen for regulatory reasons before we explain it: the observation may be nothing. That possibility deserves a sentence and…
-
Retatrutide dose escalation in the published trials Replied, post #54 · Compounds › Retatrutide · 27 Mar 2025 · 16 likes That is the distinction I keep failing to hold on to. Written down now.
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #10 · Devices › Cold chain · 21 Mar 2025 · 30 likes Recording arrival condition on ordinary deliveries is what makes the record useful. A file containing only the bad arrivals cannot tell you how often they happen. That…
-
Consistent declarations and why they matter more than clever ones Replied, post #137 · Sourcing › Logistics · 6 Mar 2025 · 0 likes The version of consistent declarations that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #38 · Practice › Reconstitution · 28 Feb 2025 · 5 likes Post #34 and I disagree about the size of the effect, not about the direction. How much of the diluent volume the powder itself displaces: for a small peptide vial, the…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #106 · Access › Insurance & coverage · 6 Jan 2025 · 25 likes Reading back through, this was answered upthread and I missed it. My fault.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #14 · Compounds › Semaglutide · 1 Jan 2025 · 26 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
-
Second pass at: Albumin binding and how it produces a long half-life Replied, post #7 · Pharmacology › Pharmacokinetics · 28 Nov 2024 · 0 likes Picking up post #4: that is the part I would want checked first. The accumulation ratio for weekly dosing with a week-long half-life is around two, which is why the…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #16 · Wellbeing › Mental health · 11 Nov 2024 · 3 likes Adding the measurement that post #14 says would settle it. I keep a log for anxiety specifically because my memory of it turned out to be systematically wrong in one…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #32 · Meta › Wiki maintenance · 10 Nov 2024 · 22 likes Housekeeping: three documents now carry the same paragraph verbatim because it was copied rather than linked. One of them should hold it and the other two should point…
-
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #7 · Compounds › Tirzepatide · 2 Nov 2024 · 15 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
-
Progressive overload when the scale is falling — one year on Replied, post #126 · Nutrition & Training › Resistance training · 5 Oct 2024 · 20 likes Post #124 put the caveat in the right place and I want to underline it. Checked the Progressive overload claim against the primary source this morning. It survives,…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #52 · Practice › Administration · 24 Sep 2024 · 0 likes Answering the question post #48 raises rather than the one it answers. Adding what did not work for me on site rotation scheme, since the failures never get written up…
-
Gallbladder disease risk with rapid weight loss Replied, post #7 · Clinical › Comorbidities · 7 Sep 2024 · 0 likes The version of gallbladder disease risk that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #48 · Clinical › Prescriber conversations · 31 Aug 2024 · 0 likes Everything in post #46 holds. The case it does not cover is the one I have. A question phrased as "what would you want to see before considering X" is answerable and is…
-
Correlation in a self-tracked dataset: what it can support Replied, post #125 · Research Methods › Statistics · 25 Aug 2024 · 30 likes Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice that should have been pre-specified.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #14 · Nutrition & Training › Hydration & electrolytes · 27 Jul 2024 · 12 likes On post #12 — agreed on the reasoning, with one qualification. Posting my Sodium numbers with the method attached so they can be discounted properly. Uncontrolled,…
-
Journal club: FLOW and the renal composite, component by component Replied, post #57 · Evidence › Journal club · 14 Jul 2024 · 5 likes No disagreement from me. Posting only so the question does not look ignored.